江西生物(06915)全资子公司获得兽用破伤风抗毒素批准文号批件

智通财经07-03

智通财经APP讯，江西生物(06915)发布公告，本公司旗下全资子公司赤峰博恩药业有限公司近期成功取得兽用破伤风抗毒素产品《兽药产品批准文号批件》(批准文号批件)。兽用破伤风抗毒素主要用于预防及治疗动物破伤风感染，通过中和破伤风毒素，为存在破伤风感染风险的动物提供被动免疫保护。董事会认为，本次取得上述批准文号批件，进一步丰富了本集团产品组合，为本集团持续拓展动物健康市场奠定了基础，有助于进一步提升...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2648163969?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-03 06:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648163969","market":"sh","top_or_hot":-1,"title":"江西生物(06915)全资子公司获得兽用破伤风抗毒素批准文号批件","media":"智通财经","content":"<div>\n<p>智通财经APP讯，江西生物(06915)发布公告，本公司旗下全资子公司赤峰博恩药业有限公司近期成功取得兽用破伤风抗毒素产品《兽药产品批准文号批件》(批准文号批件)。兽用破伤风抗毒素主要用于预防及治疗动物破伤风感染，通过中和破伤风毒素，为存在破伤风感染风险的动物提供被动免疫保护。董事会认为，本次取得上述批准文号批件，进一步丰富了本集团产品组合，为本集团持续拓展动物健康市场奠定了基础，有助于进一步提升...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1462659.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>江西生物(06915)全资子公司获得兽用破伤风抗毒素批准文号批件</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n江西生物(06915)全资子公司获得兽用破伤风抗毒素批准文号批件\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-03 06:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1462659.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，江西生物(06915)发布公告，本公司旗下全资子公司赤峰博恩药业有限公司近期成功取得兽用破伤风抗毒素产品《兽药产品批准文号批件》(批准文号批件)。兽用破伤风抗毒素主要用于预防及治疗动物破伤风感染，通过中和破伤风毒素，为存在破伤风感染风险的动物提供被动免疫保护。董事会认为，本次取得上述批准文号批件，进一步丰富了本集团产品组合，为本集团持续拓展动物健康市场奠定了基础，有助于进一步提升...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1462659.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06915","symbol_name":"江西生物","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1462659.html","article_id":"2648163969","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648163969","pubTimestamp":1783032522,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，江西生物(06915)发布公告，本公司旗下全资子公司赤峰博恩药业有限公司近期成功取得兽用破伤风抗毒素产品《兽药产品批准文号批件》(批准文号批件)。兽用破伤风抗毒素主要用于预防及治疗动物破伤风感染，通过中和破伤风毒素，为存在破伤风感染风险的动物提供被动免疫保护。董事会认为，本次取得上述批准文号批件，进一步丰富了本集团产品组合，为本集团持续拓展动物健康市场奠定了基础，有助于进一步提升本集团的综合竞争力及长期发展潜力。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06915":"江西生物"},"translate_title":"Jiangxi Bio (06915) wholly-owned subsidiary obtained the approval document of veterinary tetanus antitoxin approval number","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06915":1.5},"content_text":"智通财经APP讯，江西生物(06915)发布公告，本公司旗下全资子公司赤峰博恩药业有限公司近期成功取得兽用破伤风抗毒素产品《兽药产品批准文号批件》(批准文号批件)。兽用破伤风抗毒素主要用于预防及治疗动物破伤风感染，通过中和破伤风毒素，为存在破伤风感染风险的动物提供被动免疫保护。董事会认为，本次取得上述批准文号批件，进一步丰富了本集团产品组合，为本集团持续拓展动物健康市场奠定了基础，有助于进一步提升本集团的综合竞争力及长期发展潜力。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648163969","isCrawlerRequest":true}